Global Financial Private Client’s Bio-Techne TECH Stock Holding History

Global Financial Private Client’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-76	Closed	-$4.46K	–	1440
2025 Q1	$4.46K	Buy	76 +16	+27%	+$1.08K	﹤0.01%	707
2024 Q4	$4.32K	Buy	60 +4	+7%	+$294	﹤0.01%	649
2024 Q3	$4.48K	Hold	56	–	–	﹤0.01%	653
2024 Q2	$4.01K	Hold	56	–	–	﹤0.01%	521
2024 Q1	$3.89K	Hold	56	–	–	﹤0.01%	541
2023 Q4	$4.32K	Hold	56	–	–	﹤0.01%	526
2023 Q3	$3.76K	Hold	56	–	–	﹤0.01%	524
2023 Q2	$4.54K	Hold	56	–	–	﹤0.01%	511
2023 Q1	$4.13K	Hold	56	–	–	﹤0.01%	520
2022 Q4	$4.64K	Hold	56	–	–	﹤0.01%	495
2022 Q3	$4.1K	Hold	56	–	–	﹤0.01%	484
2022 Q2	$4.95K	Hold	56	–	–	﹤0.01%	456
2022 Q1	$6.07K	Hold	56	–	–	﹤0.01%	453
2021 Q4	$7.24K	Hold	56	–	–	﹤0.01%	422
2021 Q3	$6.91K	Hold	56	–	–	﹤0.01%	375
2021 Q2	$6.36K	Hold	56	–	–	﹤0.01%	392
2021 Q1	$5.44K	Hold	56	–	–	﹤0.01%	355
2020 Q4	$4.45K	Hold	56	–	–	﹤0.01%	360
2020 Q3	$3.48K	Hold	56	–	–	﹤0.01%	365
2020 Q2	$3.72K	Hold	56	–	–	﹤0.01%	405
2020 Q1	$2.6K	Hold	56	–	–	﹤0.01%	428
2019 Q4	$3.07K	Buy	+56	New	+$2.94K	﹤0.01%	441

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Global Financial Private Client's TECH Position: Q2 2025 in Review

Global Financial Private Client sold out of Bio-Techne (TECH) in Q2 2025, closing a stake of 76 shares — an estimated $4.46K sold.

Global Financial Private Client first reported a position in TECH in Q4 2019 and held it in 22 quarters. The position peaked at $7.24K in Q4 2021. 556 funds tracked by Wall St. Rank hold TECH as of Q2 2025.

Global Financial Private Client reported no remaining Bio-Techne position as of Q2 2025 after selling out during the quarter.
Global Financial Private Client sold 76 Bio-Techne shares in Q2 2025, an estimated $4.46K.
Global Financial Private Client first reported a position in Bio-Techne in Q4 2019 and held it in 22 quarters.
Global Financial Private Client's Bio-Techne position peaked at $7.24K in Q4 2021.
556 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.